Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Drug Discovery & Development
A neutral forum to enhance world health
The DIA is critical to the advancement of drug discovery. Why? DIA President Theresa Musser tells us more.
Size Matters
How the tiny world of nanotechnology is having a big impact on the pharma industry. By Magforce Nanotechnologies AG
ChemiScreen novel GPCR stable cell lines for calcium mobilization assay platforms
Historically, successful drugs have been discovered without an understanding of the molecular details of their mechanism of action.
Optimizing Efficiency with Electronic Regulatory Submissions
A large generic pharmaceutical company has research, development, manufacturing and distribution operations worldwide. By Waters
Standard Issue
NGP speaks with Professor Antony N Davies, Senior Marketing Manager, Waters Informatics about how the use of standards is a powerful enabling technology for moving information cleanly and in a compliant manner between applications.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.